Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      John M. Stewart Image

      John M. Stewart, M.D.

      Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

      About Dr. John M. Stewart

      I am a professor in the Department of Pathology and the Chief of the Cytopathology Section.  I graduated from the University of Virginia Medical School and completed residency training in Anatomic and Clinical Pathology at the University of Rochester Medical Center.  I joined the faculty at MD Anderson Cancer Center in 2001 after completing the Cytopathology Fellowship here.

      I am a full-time pathologist and 100% of my clinical service is in cytopathology.  I have a special interest and expertise in the interpretation of endobronchial ultrasound-guided fine needle aspirations and in the clinical use and pre-analytic evaluations of cytologic samples for molecular testing.  I have given local, national, and international lectures and workshops on these subjects for pathologists and bronchoscopists. 


      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Pathology, Cytotechnology program, School of Health Professionals, Houston, TX

      Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Professor, Pathology, Cytotechnology Program, School of Health Professionals, Houston, Texas

      Education & Training

      Degree-Granting Education

      1993University of Virginia, Charlottesville, Virginia, US, MD
      1987University of Virginia, Charlottesville, Virginia, US, Biophysical Chemistry, Ph.D
      1982Georgetown University, Washington, US, Chemistry, BS

      Postgraduate Training

      2000-2001Fellow, Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      1999-2000Fellow, Forensic Pathology, Monroe County Medical Examiner’s Office, Rochester, New York
      1998-1999Chief Resident, University of Rochester Medical Center, Rochester, New York
      1996-1998Wilmot Cancer Research Fellow, University of Rochester Medical Center, Rochester, New York
      1993-1996Resident, University of Rochester Medical Center, Rochester, New York
      1990-1991Postsophmore Fellow, University of Virginia, Charlottesville, Virginia
      1989-1990Postdoctoral Fellow, University of Virginia, Charlottesville, Virginia

      Licenses & Certifications

      2012Cytopathology
      2004Texas Medical Board Physician License
      2004Anatomic and Clinical Pathology
      2000DEA
      2000DEA
      1997Not specified
      1997Not specified

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Pathology, Cytotechnology Program, School of Health Professionals, Houston, TX, 2011 - 2016

      Associate Professor, Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2010 - 2016

      Assistant Professor, The University of Texas M. D. Anderson Cancer Center, Cytotechnology Program, School of Health Professionals, Houston, TX, 2007 - 2011

      Assistant Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2010

      Instructor, Department of Pathology, University of Rochester Medical Center, Rochester, NY, 1996 - 1998

      Administrative Appointments/Responsibilities

      Director, Cytopathology Fellowship Training Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - 2021

      Chief, Section of Cytopathology, Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2023

      Other Professional Positions

      Medical Director, Cytopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020

      Medical Director, Cytopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020

      Medical Director, Cytopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020

      Director, Cytopathology Fellowship Training Program, MD Anderson Cancer Center, Housto, TX, 2019 - 2021

      Medical Director, Cytopathology Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2022

      Quality Assessment Coordinator - prepare and present a monthly (QI/QA) conference for the faculty,, Quality Improvement, Houston, TX, 2008 - 2013

      Extramural Institutional Committee Activities

      Chair, Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Chair, Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2018

      Member, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2021

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2011 - 2012

      Member, Medical Record Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2018

      Member, Clinical Research Committee (CRC-1), The University of Texas MD Anderson Cancer Center, 2007 - 2010

      Editorial Activities

      Associate Editor, ASC Bulletin, 2006 - 2008

      Professional Memberships

      Texas Society of Cytology

      2006

      Selected Presentations & Talks

      Local Presentations

      1. 2020. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      2. 2019. Lecture: Troubleshooting and Optimizing EBUS. Invited. 2nd Annual Cytopathology and Small Biopsy Update and Review. Houston, Texas, US.
      3. 2019. Troubleshooting and Optimizing EBUS. Invited. Texas Medical Center 2nd Annual Cytopathology and Small Biopsy Update and Review. Houston, Texas, US.
      4. 2019. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      5. 2019. Updates in Pediatric Cytopathology. Invited. The University of Texas MD Anderson Cancer Center Diagnostic Pathology Course. Houston, Texas, US.
      6. 2018. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      7. 2017. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      8. 2016. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      9. 2015. Role of the Cytologist in an EBUS program. Invited. Olympus Center of Excellence EBUS training bi-monthly. Houston, Texas, US.
      10. 2015. Cytology - EBUS and Mediastinum. Invited. Anatomic Pathology Citywide Didactic Conference. Houston, Texas, US.
      11. 2015. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      12. 2014. Role of the Cytologist in an EBUS program. Invited. Olympus Center of Excellence EBUS training bi-monthly. Houston, Texas, US.
      13. 2014. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      14. 2013. Role of the Cytologist in an EBUS program. Invited. Olympus Center of Excellence EBUS training bi-monthly. Houston, Texas, US.
      15. 2013. CT and EBUS FNA: Role of Immediate Assessment in the Era of Molecular Pathology. Invited. 19th Annual Course in Cytopathology. Houston, Texas, US.
      16. 2013. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      17. 2013. Cytologic Samples as a Substrate for Molecular Testing in Lung Adenocarcinoma. Invited. The University of Texas MD Anderson Cancer Center Diagnostic Pathology Course. Houston, Texas, US.
      18. 2012. Role of the Cytologist in an EBUS program. Invited. Olympus Center of Excellence EBUS training bi-monthly. Houston, Texas, US.
      19. 2012. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      20. 2011. Role of the Cytologist in an EBUS program. Invited. Olympus Center of Excellence EBUS training bi-monthly. Houston, Texas, US.
      21. 2011. Role of the Cytologist in EBUS. Invited. Interventional Pulmonology in Cancer Patients: an Intensive Hands-on Course. Houston, Texas, US.
      22. 2010. Role of the Cytologist in an EBUS program. Invited. Olympus Center of Excellence EBUS training bi-monthly. Houston, Texas, US.

      National Presentations

      1. 2019. Video Microscopy Tutorial Workshop: Troubleshooting Problems in Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations. Invited. American Society of Cytopathology Annual Meeting. Salt Lake City, UT, US.
      2. 2018. Panelist, Diagnostic Cytology. Invited. American Society of Cytopathology Annual Meeting. Washington, DC, US.
      3. 2018. Webinar: After the EBUS Needle, Optimizing Specimen Collection and Processing. Invited. The American Association for Bronchology and Interventional Pulmonology, US.
      4. 2016. Non-Microscopic Workshop: Rapid On-Site Evaluation of EBUS-TBNA in the Molecular Era. Invited. American Society of Cytopathology Annual Meeting. New Orleans, LA, US.
      5. 2015. Video Microscopy Tutorial Workshop: On-Site Evaluation for Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations in the Molecular Era. Invited. American Society of Cytopathology Annual Meeting. Chicago, IL, US.
      6. 2015. Webinar: The Challenge of Ensuring Adequacy in the New Era of Targeted Lung Cancer Therapy. Invited. Cyto E-Conference, US.
      7. 2014. Microscope Workshop: EBUS-TBNA: The Challenge of Immediate Assessment. Invited. American Society of Cytopathology Annual Meeting. Dallas, TX, US.
      8. 2014. Lecture: EBUS TBNA Specimens - Optimizing Yield for Molecular Markers. Invited. 22nd Annual Assembly of the American Association for Bronchology and Interventional Pulmonology, CHEST. Austin, TX, US.
      9. 2013. Workshop: The Challenge of Ensuring Adequacy in the New Era of Targeted Lung Cancer Therapy. Invited. American Society of Cytopathology Annual Meeting. Orlando, FL, US.
      10. 2012. Workshop: The Challenge of Ensuring Adequacy in the New Era of Targeted Lung Cancer Therapy. Invited. American Society of Cytopathology Annual Meeting. Las Vegas, NV, US.

      International Presentations

      1. 2017. Lecture: Molecular Testing Using Cytologic Substrates. Invited. Sociedad Chilena de Enfermedades Respiratorias, Curso Neumología Intervencional. Puerto Varas, CL.
      2. 2017. Lecture: EBUS CYTOLOGY: Optimizing Yield. Invited. Sociedad Chilena de Enfermedades Respiratorias, Curso Neumología Intervencional. Puerto Varas, CL.
      3. 2016. Lecture: The Use of Cytologic Substrates for Molecular Testing. Invited. Beijing Hospital Cytopathology Forum and Training Course. Beijing, CN.
      4. 2016. Lecture: EBUS TBNA: Cytopathology. Invited. Beijing Hospital Cytopathology Forum and Training Course. Beijing, CN.
      5. 2014. Lecture: Lung Cancer – Crossroads with Digestive Endoscopy. Invited. 4th ENEO (Encontro Nacional de Endoscopia Oncológica - International Oncological Gastrointestinal Endoscopy Workshop). Rio de Janeiro, US.
      6. 2014. Lecture: Optimizing EBUS Yield. Invited. 4th ENEO (Encontro Nacional de Endoscopia Oncológica - International Oncological Gastrointestinal Endoscopy Workshop). Rio de Janeiro, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2022 - 2026
      Title:Monitoring of Field Effects for the Detection of Bladder Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP220021

      Selected Publications

      Peer-Reviewed Articles

      1. Ahmed MS, Klippel-Almaraz D, Amin SE, Sura GH, Kundu UR, Yu W, Stewart JM, Gan Q, Krishnamurthy S. Utility of whole-slide imaging for rapid evaluation of thyroid FNA: A multireader prospective study. Cancer Cytopathol 133(9):e70046, 2025. e-Pub 2025. PMID: 40889104.
      2. Wang WJ, Lin P, Stewart JM, Tang G, Li S, Loghavi S, Medeiros LJ, Xu J. ALK+ Large B-Cell Lymphoma With Novel ZNF296::ALK: A Morphologic Mimic of ALK+ Anaplastic Large Cell Lymphoma. Am J Hematol 100(12):2371-2372, 2025. e-Pub 2025. PMID: 40423499.
      3. Sakshi, FN, Mallikarjuna, VS, Stewart, J, Gan, Q. Extramedullary Hematopoiesis in Serous Cavity Fluids. Diagnostic Cytopathology 53(4):167-172, 2025. e-Pub 2025. PMID: 39704045.
      4. Mir, M, Soto, F, Gomez, PA, Arroyo, RR, Suresh, A, Su, A, Gan, Q, Stewart, J, Adachi, R, Balachandran, D, Bashoura, L, Casal, RF, Dickey, BF, Eapen, GA, Evans, S, Grosu, HB, Jimenez, C, Lin, J, Ost, D, Sabath, BF, Shannon, VR, Naing, A, Gao, J, Wu, J, Suresh, K, Faiz, S, Altan, M, Sheshadri, A. Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis. Frontiers in Medicine 12, 2025. e-Pub 2025. PMID: 40529125.
      5. Fan J, Goldberg H, Torres-Cabala CA, Stewart J, Nagarajan P, Debnam M, Crouse EC, Lu T, Ferrarotto R, Esmaeli B. Complete Response to Immunotherapy Using Pembrolizumab in a Patient With Conjunctival Squamous Cell Carcinoma With Nodal Metastasis. Ophthalmic Plast Reconstr Surg 40(5):e171-e174, 2024. e-Pub 2024. PMID: 38687306.
      6. Davaro E, Tinnirello AA, Bevers TB, Milbourne A, Bassett R, Stewart J, Guo M. Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single-institution experience. Cancer Cytopathol 132(3):152-160, 2024. e-Pub 2024. PMID: 38054363.
      7. Li H, Hu X, Ning MS, Fuller GN, Stewart JM, Gilliam JC, Wu J, Le X, Vaporciyan AA, Lee JJ, Gibbons DL, Heymach JV, Futreal A, Zhang J. Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features. Front Oncol 14:1324057, 2024. e-Pub 2024. PMID: 38590653.
      8. Najjar S, Gan Q, Stewart J, Sneige N. The utility of claudin-4 versus MOC-31 and Ber-EP4 in the diagnosis of metastatic carcinoma in cytology specimens. Cancer Cytopathol 131(4):245-253, 2023. e-Pub 2023. PMID: 36522809.
      9. Faber E, Grosu H, Sabir S, San Lucas FA, Barkoh BA, Bassett RL, Luthra R, Stewart J, Roy-Chowdhuri S. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy. J Clin Pathol 75(9):612-619, 2022. e-Pub 2022. PMID: 33952592.
      10. Gan Q, Caraway NP, Ding C, Stewart JM. Primary Pancreatic Lymphoma Evaluated by Fine-Needle Aspiration. Am J Clin Pathol 158(2):242-248, 2022. e-Pub 2022. PMID: 35311939.
      11. Guo M, Khanna A, Tinnirello AA, Hwang J, Zhang P, Xu L, Li G, Dahlstrom KR, Sturgis EM, Stewart J. Detection accuracy of the Cobas HPV assay for high-risk HPV in head and neck FNA biopsy specimens. Cancer Cytopathol 130(7):523-530, 2022. e-Pub 2022. PMID: 35192231.
      12. Grosu HB, Kern R, Maldonado F, Casal R, Andersen CR, Li L, Eapen G, Ost D, Jimenez C, Frangopoulos F, Sabath B, Vakil E, Schwalk A, Marcoux M, Sagar AE, Nasim F, Lin J, Salahudin M, Arain HM, Noor L, Montanez D, Stewart J, Mullon J, Michael M, Porfyridis I. Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study. Respirology 27(5):350-356, 2022. e-Pub 2022. PMID: 35178828.
      13. Gan Q, Roy-Chowdhuri S, Duose DY, Stewart JM, Coronel E, Bhutani MS, Lee JH, Weston B, Ge PS, Ross WA, Maitra A. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB. Cancer Cytopathol 130(4):275-283, 2022. e-Pub 2022. PMID: 34905283.
      14. Liu Z, Williams M, Stewart J, Glisson BS, Fuller C, Roy-Chowdhuri S. Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma. Cancer Cytopathol 130(2):110-119, 2022. e-Pub 2022. PMID: 34375025.
      15. Yao S, Janku F, Koenig K, Tsimberidou AM, Piha-Paul SA, Shi N, Stewart J, Johnston A, Bomalaski J, Meric-Bernstam F, Fu S. Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors. Cancer Med 11(2):340-347, 2022. e-Pub 2022. PMID: 34841717.
      16. Guo M, Shlyakhova N, Khanna A, Tinnirello AA, Schmeler KM, Hwang J, Sturgis EM, Stewart J. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening. J Am Soc Cytopathol 10(4):399-405, 2021. e-Pub 2021. PMID: 33967024.
      17. Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, Tang Z, Bassett R, Manekia J, Barkoh BA, Dang H, Roy-Chowdhuri S. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers. Cancer Cytopathol 129(5):374-382, 2021. e-Pub 2021. PMID: 33119213.
      18. Yao S, Janku F, Subbiah V, Stewart J, Patel SP, Kaseb A, Westin SN, Naing A, Tsimberidou AM, Hong D, Piha-Paul SA, Shi N, Johnston A, Bomalaski J, Fu S. Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies. Br J Cancer 124(9):1533-1539, 2021. e-Pub 2021. PMID: 33674736.
      19. Hennessy, M, Wahba, A, Felix, K, Cabrera, M, Segura, MG, Kundra, V, Ravoori, M, Stewart, J, Kleinerman, ES, Jensen, VB, Gopalakrishnan, V, Pena, R, Quach, P, Kim, G, Kivimäe, S, Madakamutil, L, Overwijk, W, Zalevsky, J, Gordon, N. Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma. International journal of cancer 148(8):1928-1937, 2021. e-Pub 2021. PMID: 33152115.
      20. Hou T, Landon G, Stewart J, Roy-Chowdhuri S. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions. Cancer Cytopathol 129(1):75-82, 2021. e-Pub 2021. PMID: 32809259.
      21. Hou T, Stewart JM, Lee JH, Gan Q. Solid Tumor Metastases to the Pancreas Diagnosed Using Fine-Needle Aspiration. Am J Clin Pathol. e-Pub 2020. PMID: 32651950.
      22. Harding WC, Marcoux M, Casal RF, Bashoura L, Stewart J, Lee HC, Faiz SA. Lung Nodule in a Patient with Multiple Myeloma. Am J Respir Crit Care Med. e-Pub 2020. PMID: 32730097.
      23. Zafereo M, McIver B, Vargas-Salas S, Domínguez JM, Steward DL, Holsinger FC, Kandil E, Williams M, Cruz F, Loyola S, Solar A, Roa JC, León A, Droppelman N, Lobos M, Arias T, Kong CS, Busaidy N, Grubbs EG, Graham P, Stewart J, Tang A, Wang J, Orloff L, Henríquez M, Lagos M, Osorio M, Schachter D, Franco C, Medina F, Wohllk N, Diaz RE, Veliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Traipe E, Marín L, Miranda G, Bruce E, Bracamonte M, Mena N, González HE. A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials. Thyroid 30(5):704-712, 2020. e-Pub 2020. PMID: 31910118.
      24. Lyapichev KA, Piña-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RN. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol 33(3):367-379, 2020. e-Pub 2020. PMID: 31383966.
      25. Chen L, Jing H, Gong Y, Tam AL, Stewart J, Staerkel G, Guo M. Diagnostic efficacy and molecular testing by combined fine needle aspiration and core needle biopsy in patients with a lung nodule. Cancer Cytopathol 128(3):201-206, 2020. e-Pub 2020. PMID: 31913583.
      26. Grosu HB, Arriola A, Stewart J, Ma J, Bassett R, Hernandez M, Ost D, Roy-Chowdhuri S. PD-L1 detection in histology specimens and matched pleural fluid cell blocks of patients with NSCLC. Respirology. e-Pub 2019. PMID: 31209954.
      27. Styskel BA, Lopez-Mattei J, Jimenez CA, Stewart J, Hagemeister FB, Faiz SA. Ibrutinib-associated Serositis in Mantle Cell Lymphoma. Am J Respir Crit Care Med 199(12):e43-e44, 2019. e-Pub 2019. PMID: 30802411.
      28. Gan Q, Stewart JM, Valik E, Eapen G, Caraway NP. Cytologic Evaluation of Positron Emission Tomography-Computed Tomography-Positive Lymph Nodes Sampled by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Experience at a Large Cancer Center. Arch Pathol Lab Med. e-Pub 2019. PMID: 31063012.
      29. Ye W, Hannigan B, Zalles S, Mehrotra M, Barkoh BA, Williams MD, Cabanillas ME, Edeiken-Monroe B, Hu P, Duose D, Wistuba II, Medeiros LJ, Stewart J, Luthra R, Roy-Chowdhuri S. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules. Cancer Cytopathol 127(3):146-160, 2019. e-Pub 2019. PMID: 30620446.
      30. Casal RF, Sarkiss M, Jones AK, Stewart J, Tam A, Grosu HB, Ost DE, Jimenez CA, Eapen GA. Cone beam computed tomography-guided thin/ultrathin bronchoscopy for diagnosis of peripheral lung nodules: a prospective pilot study. J Thorac Dis 10(12):6950-6959, 2018. e-Pub 2018. PMID: 30746241.
      31. Foshat M, Stewart J, Khoury JD, Staerkel GA, Caraway NP. Accuracy of diagnosing mantle cell lymphoma and identifying its variants on fine-needle aspiration biopsy. Cancer Cytopathol. e-Pub 2018. PMID: 30452126.
      32. Ahmed T, Vial MR, Ost D, Stewart J, Hasan MA, Grosu HB. Non-small cell lung cancer transdifferentiation into small cell lung cancer: A case series. Lung Cancer 122:220-223, 2018. e-Pub 2018. PMID: 30032836.
      33. Sagiv O, Stewart J, Esmaeli B. Periocular Ecchymoses in Neuroblastoma Metastatic to the Orbit. Ophthalmology 125(7):983, 2018. e-Pub 2018. PMID: 29935671.
      34. Kazzaz F, O'Connell OJ, Vial MR, Stewart J, Grosu HB. Everolimus-induced Chylous Effusion. Am J Respir Crit Care Med 198(1):120-122, 2018. e-Pub 2018. PMID: 29630393.
      35. Dhupkar P, Gordon N, Stewart J, Kleinerman ES. Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases. Cancer Med 7(6):2654-2664, 2018. e-Pub 2018. PMID: 29733528.
      36. Smith AL, Williams MD, Stewart J, Wang WL, Krishnamurthy S, Cabanillas ME, Roy-Chowdhuri S. Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma. Cancer Cytopathol 126(6):406-413, 2018. e-Pub 2018. PMID: 29579361.
      37. Vakil E, Ost D, Vial MR, Stewart J, Sarkiss MG, Morice RC, Casal RF, Eapen GA, Grosu HB. Non-specific pleuritis in patients with active malignancy. Respirology 23(2):213-219, 2018. e-Pub 2018. PMID: 29024191.
      38. Vial MR, O'Connell OJ, Grosu HB, Hernandez M, Noor L, Casal RF, Stewart J, Sarkiss M, Jimenez CA, Rice D, Mehran R, Ost DE, Eapen GA. Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study. Respirology 23(1):76-81, 2018. e-Pub 2018. PMID: 28857362.
      39. Kleinerman ES, Yu L, Dao J, Hayes-Jordan AA, Lindsey B, Kawedia JD, Stewart J, Gordon N. Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing. Sarcoma 2018:3143096, 2018. e-Pub 2018. PMID: 29610563.
      40. Sudhakaran S, Bashoura L, Stewart J, Balachandran DD, Faiz SA. Pulmonary Cryptococcus Presenting as a Solitary Pulmonary Nodule. Am J Respir Crit Care Med 196(9):1217-1218, 2017. e-Pub 2017. PMID: 28892401.
      41. Hernandez Tejada F, Yedururi S, Kumar R, Stewart J, Tarek N. Ganglioneuroma with Disseminated Bone Lesions. Pediatr Blood Cancer 64(4), 2017. e-Pub 2017. PMID: 28221728.
      42. Grosu HB, Vial MR, Vakil E, Casal RF, Eapen GA, Morice R, Stewart J, Sarkiss MG, Ost DE. Pleural Touch Preparations and Direct Visualization of the Pleura during Medical Thoracoscopy for the Diagnosis of Malignancy. Ann Am Thorac Soc. e-Pub 2017. PMID: 28406718.
      43. Ong PG, Casal RF, Stewart J, Eapen GA, Faiz SA. Metastatic Cancer Mimicking a Mycetoma. Am J Respir Crit Care Med. e-Pub 2017. PMID: 28207281.
      44. Roy-Chowdhuri S, Chen H, Singh RR, Krishnamurthy S, Patel KP, Routbort MJ, Manekia J, Barkoh BA, Yao H, Sabir S, Broaddus RR, Medeiros LJ, Staerkel G, Stewart J, Luthra R. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. Mod Pathol. e-Pub 2017. PMID: 28084342.
      45. Liu Q, Stewart J, Wang H, Rashid A, Zhao J, Katz MH, Lee JE, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, Krishnan S, Wang H. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma. PLoS One 12(2):e0171985, 2017. e-Pub 2017. PMID: 28187218.
      46. Vial MR, O’Connell OJ, Grosu HB, Hernandez M, Noor L, Casal RF, Stewart J, Sarkiss M, Jimenez CA, Rice D, Mehran R, Ost DE, Eapen GA. Diagnostic utility of endobronchial ultrasound guided mediastinal lymph node sampling in early stage non-small cell lung cancer. Respirology, 2017. e-Pub 2017.
      47. McCroskey Z, Khoury JD, Stewart JM, Caraway, NP. Sensitivity of fine-needle aspiration biopsy for diagnosing and grading follicular lymphomas using a multiparameter approach in a cancer center. Journal of the American Society of Cytopathology 6(2):80-88, 2017. e-Pub 2017.
      48. Vial MR, Stewart J, Lazarus DR, Eapen GA, Ost DE, Grosu HB, Jimenez CA. Unusual aetiology of a hilar mass in a man with history of thyroid cancer. Thorax 71(12):1167-1168, 2016. e-Pub 2016. PMID: 27422794.
      49. Roy-Chowdhuri S, Stewart J. Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing-The MD Anderson Experience. Arch Pathol Lab Med. e-Pub 2016. PMID: 27333361.
      50. Roy-Chowdhuri S, Chow CW, Kane MK, Yao H, Wistuba II, Krishnamurthy S, Stewart J, Staerkel G. Optimizing the DNA yield for molecular analysis from cytologic preparations. Cancer Cytopathol 124(4):254-60, 2016. e-Pub 2016. PMID: 26630358.
      51. Goswami RS, Luthra R, Singh RR, Patel KP, Routbort MJ, Aldape KD, Yao H, Dang HD, Barkoh BA, Manekia J, Medeiros LJ, Roy-Chowdhuri S, Stewart J, Broaddus RR, Chen H. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors. Am J Clin Pathol 145(2):222-37, 2016. e-Pub 2016. PMID: 27124905.
      52. Roy-Chowdhuri S, Goswami RS, Chen H, Patel KP, Routbort MJ, Singh RR, Broaddus RR, Barkoh BA, Manekia J, Yao H, Medeiros LJ, Staerkel G, Luthra R, Stewart J. Factors affecting the success of next-generation sequencing in cytology specimens. Cancer Cytopathol 123(11):659-68, 2015. e-Pub 2015. PMID: 26230354.
      53. Maher OM, Prieto VG, Stewart J, Herzog CE. Characterization of metastatic angiomatoid fibrous histiocytoma. J Pediatr Hematol Oncol 37(4):e268-71, 2015. e-Pub 2015. PMID: 25757019.
      54. Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF V600: clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2015. PMID: 25148578.
      55. Gavini H, Arukal VD, Stewart J, Lee JH. Medulloblastoma metastatic to the pancreas: a case report. Gastrointestinal Intervention 3(2):116-119, 2014. e-Pub 2014.
      56. Guma SR, Lee DA, Yu L, Gordon N, Hughes D, Stewart J, Wang WL, Kleinerman ES. Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis. Pediatr Blood Cancer 61(4):618-26, 2014. e-Pub 2014. PMID: 24136885.
      57. Wang J, Katz RL, Stewart J, Landon G, Guo M, Gong Y. Fine-needle aspiration diagnosis of lymphomas with signet ring cell features: potential pitfalls and solutions. Cancer Cytopathol 121(9):525-32, 2013. e-Pub 2013. PMID: 23536424.
      58. Rao-Bindal K, Koshkina NV, Stewart J, Kleinerman ES. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases. Curr Cancer Drug Targets 13(4):411-22, 2013. e-Pub 2013. PMID: 23410027.
      59. Landon G, Stewart J, Deavers M, Lu K, Sneige N. Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility. Gynecol Oncol 125(3):683-6, 2012. e-Pub 2012. PMID: 22425664.
      60. Zage PE, Nolo R, Fang W, Stewart J, Garcia-Manero G, Zweidler-McKay PA. Notch pathway activation induces neuroblastoma tumor cell growth arrest. Pediatr Blood Cancer 58(5):682-9, 2012. e-Pub 2012. PMID: 21744479.
      61. Singh A, Rokes C, Gireud M, Fletcher S, Baumgartner J, Fuller G, Stewart J, Zage P, Gopalakrishnan V. Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells. Cancer 117(22):5189-202, 2011. e-Pub 2011. PMID: 21523764.
      62. Billah S, Stewart J, Staerkel G, Chen S, Gong Y, Guo M. EGFR and KRAS Mutations in Lung Carcinoma. Cancer Cytopathol 119(2):111-7, 2011. e-Pub 2011. PMID: 21400670.
      63. Hu Q, Gao F, Tian W, Ruteshouser EC, Wang Y, Lazar A, Stewart J, Strong LC, Behringer RR, Huff V. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest 121(1):174-83, 2011. e-Pub 2011. PMID: 21123950.
      64. dePadua Silva L, Patah PA, Saliba RM, Szewezyk NA, Gilman L, Neumann J, Han XY, Tarrand J, Ribeiro R, Gulbis A, Shpall EJ, Jones R, Popat U, Walker JA, Petropoulos D, Chiattone A, Stewart J, El-Zimaity M, Anderlini P, Giralt S, Champlin RE, and de Lima M. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 95:1183-1190, 2010. e-Pub 2010.
      65. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic Ultrasound-Guided Fine Needle Aspiration for Staging of Malignant Pleural Mesothelioma. Ann Thorac Surg 88:862-86, 2009. e-Pub 2009.
      66. Lee JH, Stewart J, Ross WA, Anandasabapathy S, Xiao L, Staerkel G. Blinded Prospective Comparison of the Performance of 22-Gauge and 25-Gauge Needles in Endoscopic Ultrasound-Guided Fine Needle Aspiration of the Pancreas and Peri-pancreatic Lesions. Dig Dis Sci 54:2274-2281, 2009. e-Pub 2009. PMID: 19669880.
      67. Subbiah V, Huff V, Wolff JE, Ketonen L, Lang FF, Stewart J, Langford L, Herzog CE. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome. Pediatr Blood Cancer 53:1349-1351, 2009. e-Pub 2009. PMID: 19653292.
      68. Reading CF, Schlette EJ, Stewart JM, Keating MJ, Katz RL, Caraway NP. Fine-needle aspiration biopsy findings in patients with small lymphocytic lymphoma transformed to hodgkin lymphoma. Am J Clin Pathol 128(4):571-8, 2007. e-Pub 2007. PMID: 17875507.
      69. Gong Y, Caraway N, Stewart J, Staerkel G. Metastatic ductal carcinoma of the prostate: cytologic features and clinical findings. Am J Clin Pathol 126(2):302-309, 2006. e-Pub 2006.
      70. Goy A, Stewart J, Barkoh B, Remache Y, Katz R, Sneige N, Gilles F. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma. Cancer 108(1):10-20, 2006. e-Pub 2006.
      71. Guan H, Jia SF, Zhou Z, Stewart J, Kleinerman ES. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo. Clin Cancer Res 11(5):2008-17, 2005. e-Pub 2005. PMID: 15756027.
      72. Gordon N, Arndt C, Hawkins D, Doherty D, Inwards C, Munsell M, Stewart J, Koshkina N, Kleinerman E. Fas expression in lung metastasis from osteosarcoma patients. J Ped Hem Onc 27(11):611-615, 2005. e-Pub 2005.
      73. Assad L, Resetkova E, Oliveira V, Sun W, Stewart J, Katz R, Caraway N. Cytologic features of renal medullary carcinoma. Cancer 105(1):28-34, 2005. e-Pub 2005.
      74. Goy A, Remache YK, Gu J, Stewart J, Hayes KJ, Gold D, Jiang Y, Barkoh BA, Katz R, Cabanillas F, Gilles F. Establishment and characterization of a new mantle cell lymphoma cell line M-1. Leuk Lymphoma 45(6):1255-60, 2004. e-Pub 2004. PMID: 15360009.
      75. Lafleur E, Nkoshkina N, Stewart J, Jia S, Worth L, Duan X, Kleinerman E. Increased Fas expression reduces metastatic potential of human osteosarcoma cells. Clin Cancer Res 10(23):8814-8819, 2004. e-Pub 2004.
      76. Wang S, Stewart JM, Ross MI, Prieto VG. Extensive pigmented villonodular synovitis with markedly pigmented lymphadenopathy and its implication for differential diagnosis with malignant melanoma. Ann Diagn Pathol 7(2):95-9, 2003. e-Pub 2003. PMID: 12715334.
      77. Caraway N, Fanning C, Stewart J, Tarrand J, Weber K. Coccidiodomycosis osteomyelitis masquerading as a bone tumor. Acta Cytol 47(5):777-782, 2003. e-Pub 2003.
      78. Stewart J, Krishnamurthy S. Fine-needle aspiration cytology of a case of HIV-associated anaplastic myeloma. Diagn Cytopathol 27(4):218-22, 2002. e-Pub 2002.
      79. Rubio A, Vestner A, Stewart J, Forbes N, Conwell Y, Cox C. Suicide and Alzheimer’s pathology in the elderly: a case-control study. Biol Psychiatry 49(2):137-145, 2001. e-Pub 2001.
      80. O’Keefe R, Rosier R, Teot L, Stewart J, Hicks D. Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction. Iowa Orthopaedic Journal 18:26-34, 1998. e-Pub 1998.
      81. Stewart J, Kozlowski P, Sowden M, Messing E, Smith H. A quantitative assay for assessing allelic proportions by iterative gap ligation. Nucl Acids Res 26(4):961-966, 1998. e-Pub 1998.
      82. Rubio A, Rifkin D, Powers J, Patel U, Stewart J, Faust P, Goldman J, Mohr J, Numaguchi Y, Jensen K. Phenotypic variability of CADASIL and Novel Morphologic Findings. Acta Neuropath 94(3):247-254, 1997. e-Pub 1997.
      83. Metcalf D, Stewart J, Snyder S, Grisham C, Richardson F. Chiral recognition between dissymmetric Ln(dpa)3-3 and Co(III)-nucleotide complexes in aqueous solution: enantioselective luminescence quenching as a probe of intermolecular chiral discrimination. Inorg Chem 31(12):2445-2455, 1992. e-Pub 1992.
      84. Stewart J, Jorgensen P, Grisham C. Nuclear Overhouser Effect studies of the conformation of Co(NH3)4ATP bound to kidney Na,K-ATPase. Biochem 28(11):4693-4701, 1989. e-Pub 1989.
      85. Stewart J, Grisham C. 1H Nuclear Magnetic Resonance studies of the conformation of an ATP analogue at the active site of Na,K-ATPase from kidney medulla. Biochem 27(13):4840-4848, 1988. e-Pub 1988.

      Invited Articles

      1. Caraway N, Stewart J, Blakely M. Primary effusion lymphoma. Pathology Case Revies 11(2):78-87, 2006. e-Pub 2006.
      2. Herzog C, Stewart J, Blakely M. Pediatric Soft Tissue Sarcomas. Surgical Oncology Clinics of North America 12(2):419-448, 2003. e-Pub 2003.
      3. Stewart J, Kuntzweiler T, Klevickis C, Grisham C. Structural features of intermediate states of sheep kidney Na,K-ATPase. Society of General Physiologists Series 46:143-158, 1991. e-Pub 1991.
      4. Klemens M, Stewart J, Mehaney J, Kuntzweiler T, Sattler M, Grisham C. NMR and ESR studies of active site structures and intermediate states of kidney Na,K-ATPase and SR Ca-ATPase. Advances in Biotechnology of Membrane Ion Transport 51:107-120, 1988. e-Pub 1988.

      Review Articles

      1. Marques-Piubelli ML, Lyapichev KA, Fnu A, Adrada B, Stewart J, Hunt KK, Clemens MW, Iyer S, Wu Y, El Hussein S, Xu J, Ok CY, Li S, Pierson DM, Ferrufino-Schmidt MC, Nahmod KA, Yoga A, Hunsicker L, Evans MG, Resetkova E, Qiu L, Khanlari M, Garces SA, Bueso-Ramos CE, Medeiros LJ, Miranda RN. The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance. Am J Surg Pathol 48(6):e43-e64, 2024. e-Pub 2024. PMID: 38451836.
      2. Marques-Piubelli ML, Medeiros LJ, Stewart J, Miranda RN. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Updates in Diagnosis and Specimen Handling. Surg Pathol Clin 16(2):347-360, 2023. e-Pub 2023. PMID: 37149362.
      3. Hosseini SM, Stewart JM. Cytopathology assistance for optimizing interventional diagnostic procedures. Semin Diagn Pathol 39(6):389-393, 2022. e-Pub 2022. PMID: 35931593.
      4. Lanke, G, Stewart, J, Lee, JH. Pancreatic paraganglioma diagnosed by endoscopic ultrasound-guided fine needle aspiration. World journal of gastroenterology 27(37):6322-6331, 2021. e-Pub 2021. PMID: 34712035.

      Professional Educational Materials

      1. . Small sample tissue acquisition and processing for diagnosis and biomarker-directed therapy of NSCLC (Webinars). World Association for Bronchoscopy and International Pulmonology. Fourteen international faculty from various medical disciplines participated in the development of a series of three non-CME webcasts using a clinical stem, patient-centered case simulation format designed for a global audience of health care providers caring for patients with nonsmall cell lung cancer (NSCLC). (http://www.wabipacademy.com/webcast/), 2014.

      Other Articles

      1. Mir, M, Soto, F, Gomez, PA, Arroyo, RR, Suresh, A, Su, A, Gan, Q, Stewart, J, Adachi, R, Balachandran, D, Bashoura, L, Casal, RF, Dickey, BF, Eapen, GA, Evans, S, Grosu, HB, Jimenez, C, Lin, J, Ost, D, Sabath, BF, Shannon, VR, Naing, A, Gao, J, Wu, J, Suresh, K, Faiz, S, Altan, M, Sheshadri, A Correction. Frontiers in Medicine 12, 2025. PMID: 40641984.

      Editorials

      1. Grosu HB, Stewart J. Pleural Touch Preparations for Medical Thoracoscopy: Are We There Yet?. J Bronchology Interv Pulmonol 28(2):93-94, 2021. PMID: 33753702.

      Abstracts

      1. Ahmed, M, Klippel, D, Amin, S, Sura, G, Kundu, U, Y, Wendong, Stewart, J, Gan, Q, Krishnamurthy, S. Utility of Whole Slide Imaging for Evaluation of Thyroid Fine Needle Aspiration: A Multi-reader Prospective Study, 2024. e-Pub 2024.
      2. Bernieh A, Stewart J, Wang Q, Wang J, Sircar K. Adult’s Wilms Tumor: Twenty-Year Experience of a Tertiary Cancer Center with Clinicopathological and Molecular Annotation. United States and Canadian Academy of Pathology.

      Book Chapters

      1. Anton R, Stewart J. Rosai-Dorfman disease. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      2. Stewart J. FNA sample prep and triage in evaluating suspected lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      3. Caraway N, Stewart J. Primary effusion lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      4. Caraway N, Stewart J. Small lymphocytic lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      5. Caraway N, Stewart J. Lymphoplasmacytic lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      6. Caraway N, Stewart J. Mantle cell lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      7. Caraway N, Stewart J. Nodal marginal zone lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      8. Caraway N, Stewart J. Follicular lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      9. Caraway N, Stewart J. Large b-cell lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      10. Caraway N, Stewart J. Plasmacytoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      11. Caraway N, Stewart J. Plasmablastic lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      12. Caraway N, Stewart J. Peripheral t-cell lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      13. Caraway N, Stewart J. Mycosis fungoides. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      14. Caraway N, Stewart J. Angioimmunoblastic lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      15. Caraway N, Stewart J. T-cell lymphoblastic lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      16. Caraway N, Stewart J. Nodular lymphocyte-predominant hodgkin lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      17. Caraway N, Stewart J. Primary effusion lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      18. Caraway N, Stewart J. Mediastinal large b-cell lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      19. Caraway N, Stewart J. ALK(+) anaplastic large cell lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      20. Caraway N, Stewart J. Classical hodgkin lymphoma. In: Diagnostic Pathology: Cytopathology. Amirsys, 2014.
      21. Raney R, Andrassy R, Blakely M, Fanning T, Maor M, Stewart J. Soft-Tissue Tumors. In: Pediatric Oncology. Springer Media, Inc, 2005.

      Books (edited and written)

      1. Roy-Chowdhuri, S., VanderLaan, P.A., Stewart, J.M, Santos, G.d.C. Molecular Diagnostics in Cytopathology: A Practical Handbook for the Practicing Pathologist. Springer Nature, 2019.
      2. Mody DR, Krishnamurthy S, Anton R, Thrall MJ, Caraway NP, Stewart JM, Ge Y, Takei H. Diagnostic Pathology: Cytopathology. Amirsys,, 2014.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 26, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top